Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. 1987

A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart

With the introduction of more potent immunosuppressive regimens, increasing numbers of kidney transplant recipients traditionally viewed as being at high immunologic risk for rejection and graft loss have been accepted. These include recipients of multiple grafts, sensitized patients as measured by high panel reactive antibody (PRA), and patients with current warm B or historical positive crossmatches. Since November 1983, all recipients of cadaver kidneys have been treated with cyclosporine and prednisone. In addition, most also received a short posttransplant course of antilymphocyte globulin and long-term azathioprine. With these regimens, retransplantation, sensitization, current B-cell crossmatch and historical B- and/or T-cell crossmatch do not affect graft survival.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
August 1983, Transplantation,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
December 1998, Transplantation proceedings,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
February 2000, Transplantation proceedings,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
January 1978, Surgical forum,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
October 1984, Transplantation proceedings,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
August 2005, Transplantation,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
January 1992, Transplantation,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
February 1989, Transplantation proceedings,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
January 1981, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
A O Gaber, and J R Thistlethwaite, and B W Haag, and J K Stuart, and J T Mayes, and D M Lloyd, and S Fellner, and F P Stuart
April 1984, Transplantation,
Copied contents to your clipboard!